The application of medications of alfa-lipoic acid for treatment of erectile dysfunction for patients by diabetes mellitus 2 types
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
In the trial was study the application of Alfa-lipon on the base of alfa-lipoic acid of erectile dysfunctions with patients by diabetes mellitus 2 types. The medication was manufactured by Kyiv vitamin factory
The trial was open and randomized. There was to proved, that the medication have the same effect as a hormone therapy for the pathology.
The results, which we had received, are witness about the significant increasing the erectile function after the medications using along the 12 weeks, as medications on the base of the testosterone undecanoate with antidiabetic therapy, as Alfa-lipon. On the base of the therapy were normalized concentrations of serum hormones and biochemical indicators, which are use for diabetes
diagnostics.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Shaw J.E. Global estimates of the prevalence of diabetes for 2010 and 2030 / J.E. Shaw, R.A. Sicree, P.Z. Zimmet // Diabetes Res. Clin. Pract. – 2010. – Vol. 87, No 1. – P. 4–14.
National Institutes of Health Consensus Development Panel On Impotence // JAMA. – 1993. – Vol. 270. – P. 83–90.
Оценка эффективности ингибитора фосфодиэстеразы 5-го типа в терапии нейрогенной эректильной дисфункции у пациентов с СД 1-го типа / Д.Г. Курбатов, Г.Р. Галстян, Я.Г. Шварц и др. // Проблемы эндокринологии. – 2015. – Т. 61 (4). – С. 24–28.
Mitkov Mitko D. Effect of transdermal testosterone or alpha(lipoic acid on erectile dysfunction and quality of life in patients with type 2 diabetes mellitus / Mitko D. Mitkov, Ivanka Y. Aleksandrova, Maria M. Orbetzova // Folia Medica 2013. – V. 55 (1). – Р. 55–63.
Чуканова Е.И. Влияние Тиоктацида на клинические проявления и течение дисциркуляторной энцефалопатии / Е.И. Чуканова // РМЖ. – 2010. – Т. 18, No 10. – С. 1–4.
Губергриц Н.Б. Эффективность Альфа-липоевой кислоты в лечении липидного дистресс-синдром / Н.Б. Губергриц, Н.В. Беляева // Практикуючий лікар. – 2012 – No 3. – С. 43–51.
Шавловская О.А. Тиоктовая кислота: антиоксидантная терапия неврологических заболеваний / О.А. Шавловская // РМЖ. – 2014. – No 13. – С. 960.
Antioxidant role of alpha-lipoic acid in lead toxicity / H. Gurer, H. Ozgunes, S. Oztezcan et al. // Free Radic. Biol. Med. – 1999. – Vol. 27 (1–2). – P. 75–81.
The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain:effect on health(related quality of life / M. Ranieri, M. Sciuscio, A.M. Cortese et al. // Int. J. Immunopathol. Pharmacol. – 2009. – Vol. 22 (3 Suppl). – P. 45–50.
Samy Ali Hussein. Biochemical study on the effect of alpha-lipoic acid on lipid metabolism of rats fed high fat diet. Samy Ali Hussein; Afaf D. Abdelmageid and Ahmed Mohammed Abughazalla / BVMJ. 2015 – V. 28 (1). – P. 109–119.
